Looking for a Washington, DC Plavix lawyer? Get in touch with one of our Washington, DC Plavix lawyers now.
Plavix - MSN Newsfeeds
- KIMA TV - Sherman said Apotex will pursue the Plavix case "full bore and work relentlessly" to invalidate the patent covering clopidogrel bisulfate, the active ingredient in Plavix. Sanofi obtained the patent in July 1989, naming two employees as inventors. In ...
- International Herald Tribune - NEW YORK: A federal district judge in New York has upheld the patent on the anti-clotting drug Plavix, removing a weighty uncertainty for Bristol-Myers Squibb and Sanofi-Aventis, the companies that market the widely used product. Judge Sidney Stein ...
- INS News - District Court for the Southern District of New York has upheld the validity of the patent covering Plavix's active ingredient clopidogrel bisulfate against generic firm Apotex's challenge. The court's ruling means the Plavix patent's life will run ...
- Chicago Sun-Times - Bristol-Myers Squibb Co. and Sanofi-Aventis SA won a court ruling upholding the patent for the blood-thinner Plavix, blocking generic competition to the world's third-biggest selling medicine. Separately, Bristol-Myers won accelerated U.S. review for ...
- Newsday - A Canadian company's less expensive generic version of the blood thinner Plavix has been blocked from the U.S. market until at least 2011. U.S. District Judge Sidney H. Stein said yesterday that Apotex Inc. had failed to prove during a three-week ...
- PR Newswire - District Court for the Southern District of New York has upheld the validity and enforceability of U.S. patent 4,847,265 covering clopidogrel bisulfate, the active ingredient in Plavix(R), maintaining the main patent protection for this product in ...
- Baltimore Sun - Sherman said Apotex will pursue the Plavix case "full bore and work relentlessly" to invalidate the patent covering clopidogrel bisulfate, the active ingredient in Plavix. Sanofi obtained the patent in July 1989, naming two employees as inventors. In ...
- Newsday - NEW YORK -- A Canadian company's cheap generic version of the blood thinner Plavix has been blocked from the U.S. market until at least 2011. U.S. District Judge Sidney H. Stein said Tuesday that Apotex Inc. had failed to prove during a three-week ...
- CNN Money - NEW YORK (CNNMoney.com) -- A federal judge in New York banned a generic version of the blood-thinner Plavix on Tuesday, said the drugmaker Bristol-Myers Squibb, whose stock rose more than 4 percent on the news. The ruling makes permanent a temporary ...
- Baltimore Sun - NEW YORK // A federal judge Tuesday permanently blocked a Canadian maker of a cheap generic version of blood thinner Plavix from marketing the drug, saying its version infringed on a valid patent for Plavix. U.S. District Judge Sidney H. Stein said ...
- Reuters Canada - NEW YORK (Reuters) - Canadian generic drugmaker Apotex Corp. said on Tuesday it would immediately appeal a U.S. court decision that found the patent on Plavix -- the widely-used blood clot preventer sold by Bristol-Myers Squibb Co. and Sanofi-Aventis ...
- BusinessWeek - Shares of drug makers Bristol-Myers Squibb and Paris-based Sanofi-Aventis AS rose Tuesday after a federal judge ruled privately held Canadian drug maker Apotex Inc. failed to prove that the patent for Bristol and Sanofi's blood thinner Plavix is ...
- New York Times - But Judge Stein ruled that “Sanofi has effectively rebutted a prima facie case of obviousness by demonstrating that clopidogrel bisulfate — as a whole — possesses unexpected properties that could not have reasonably been viewed as a likely ...
- CNBC - A U.S. judge ruled that the patent on the multibillion-dollar blood clot-preventing drug Plavix is valid, handing a major victory to Bristol-Myers Squibb and Sanofi-Aventis . The long-awaited ruling provides much needed certainty for one of the world ...
- Street.Com - Bristol-Myers Squibb's ( BMY - Cramer's Take - Stockpickr ) shares rose Tuesday after a judge in New York upheld the patent on Plavix, the anticoagulant that serves as its biggest-selling drug. Plavix is licensed in the U.S. to Bristol-Myers by ...
- BusinessWeek - On Mar. 19, Credit Suisse's Arnold released a report suggesting J&J could buy Bristol-Myers ( BMY ), the New York drug giant that makes the anti-clotting drug Plavix. Bristol's strong pipeline, coupled with share weakness brought on by legal challenges ...
- Wall Street Journal - On Monday, Bristol-Myers is scheduled to plead guilty in federal court in Washington to charges that it lied to the government about last year's proposed settlement of a patent dispute over its Plavix heart drug. Separately, two years of heightened ...
- Chicago Tribune - Cardiology groups encourage patients who have drug-coated stents to take aspirin and a common anti-clotting drug known as Plavix for up to a year or longer. And for patients who have had elective surgery such as a hip replacement and are told to ...
- Phramalive.com - LAVAL, QC, June 5 /CNW/ - Health Canada has approved PLAVIX(R) (clopidogrel bisulfate) in combination with ASA to reduce the rate of all-cause mortality and the rate of a combined endpoint of death, re-infarction, or stroke in patients with acute ST ...
- Wall Street Journal - PARIS -- Sanofi-Aventis SA said it isn't likely to face prosecution after a marketing partner pleaded guilty to misleading authorities last year about a failed deal to prevent sales of generic versions of the blood thinner Plavix. Bristol-Myers ...
Looking for a Washington, DC Plavix lawyer? Get in touch with one of our Washington, DC Plavix lawyers now.
Pages: 1 2 3 4 5 6 ... Next
These articles are related to: Plavix Claim, Plavix Lawsuit, Plavix Law Suit, Plavix Law Firm, Plavix Lawyer, Plavix Attorney, Plavix Side Effects Symptoms, Plavix Trial, Plavix Verdict, Plavix News, Plavix Information, Plavix Recall Lawyers, Plavix Warning, Plavix Class Action, Plavix Prescription Drug, Plavix Medication, Plavix Drugs, Clopidogrel Bisulfate Claim, Clopidogrel Bisulfate Lawsuit, Clopidogrel Bisulfate Law Suit, Clopidogrel Bisulfate Law Firm, Clopidogrel Bisulfate Lawyer, Clopidogrel Bisulfate Attorney, Clopidogrel Bisulfate Side Effects Symptoms, Clopidogrel Bisulfate Trial, Clopidogrel Bisulfate Verdict, Clopidogrel Bisulfate News, Clopidogrel Bisulfate Information, Clopidogrel Bisulfate Recall Lawyers, Clopidogrel Bisulfate Warning, Clopidogrel Bisulfate Class Action, Clopidogrel Bisulfate Prescription Drug, Clopidogrel Bisulfate Medication, Clopidogrel Bisulfate Drugs
